Extracorporeal Membrane Oxygenation Machine Market Size, Share & Trends Analysis Report By Component, By Modality (VA, VV, AV) By Patient Type, By Application, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global extracorporeal membrane oxygenation machine market was valued at USD 281.1 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.3% during the forecast period. The key driver of the market is the rising incidence of cardiopulmonary diseases and respiratory failures. According to the Centers for Disease Control and Prevention (CDC), an individual dies every 37 seconds from cardiovascular disease in the U.S. Furthermore, chronic obstructive pulmonary disease (COPD) was among the leading cause of death in the U.S. in 2018. The increasing adoption rate of extracorporeal membrane oxygenation (ECMO) has stimulated technological advancement in these systems. The advancement includes the introduction of hollow pumps, oxygenators, and heparin coated cannula used in various applications in surgeries.

The increasing number of hospitals offering ECMO services and the rising number of awareness programs are some of the factors boosting the market growth. According to the Federal Agency of Health Research and Quality, there were 6890 ECMO procedures were performed in the U.S in 2014. Thereafter, the adoption of extracorporeal membrane oxygenation machine ECMO machines in hospitals has increased significantly. According to the Extracorporeal Life Support Organization (ELSO), the number of hospitals offering ECMO services reached 264 in 2019 up from 108 in 2008.

ECMO devices are being used in the treatment of serious COVID-19 patients. However, other applications of these devices, including heart procedures showed a sharp decline in 2020. Increasing awareness about ECMO procedures and technological advancement is further propelling the market growth. Many government organizations aimed to create awareness about ECMO Procedures. Initiatives such as Global Initiative for Chronic Obstructive Lung Disease (GOLD) aim at creating awareness about COPD along with its treatment, which includes the usage of ECMO devices.

此外,增加医学界的采用率machines is catalyzing technological advancement in these systems. The latest advancement includes oxygenators, hollow pumps, and heparin-coated cannula used for various applications in surgeries. In addition, recently developed ECMO machines are smaller in size, thus increasing their portability and applications. Portable adaptors and compact ECMO machine circuits have also been developed which help in the transportation of critically ill patients.

不断增加的老年人口加上the increasing incidence of coronary heart disease is boosting the adoption of ECMO machines. Coronary heart disease is strongly associated with age and is one of the leading causes of death worldwide. According to United Nations, the number of people aged 80 years, or more is projected to reach 426 million by 2050 from 143 million in 2019 globally. However, complications associated with ECMO machines such as infections, technical failure, bleeding, and high cost of treatment may hinder the market.

Component Insight

The oxygenators segment accounted for the largest market revenue share of 34.2% in 2021 and is expected to grow at a lucrative rate during the forecast period. The large market size of oxygenators is primarily attributed to its high cost and acute exchange rate for a different system. The exchange rate of oxygenators is mainly due to mechanical failure, pump head thrombosis, and acute oxygenator thrombosis.

The pumps segment also has considerable market share owing to high cost and usage. The pumps in ECMO machines help pump blood from a patient to artificial lungs that send the blood back to the patient after oxygenation. The growth of the segment is primarily attributed to its high usage of pumps in ECMO procedures and the availability of various types of pumps such as roller, impeller, and centrifugal. These pumps are used in various applications of ECMO procedures according to their need.

Modality Insight

The veno-arterial segment accounted for the largest market revenue share of 41.8% in 2021 and is expected to grow at a healthy CAGR during the forecast period. The largest size of the segment is primarily attributed to its high usage in treating patients with cardiac arrest, assisting with algorithm life support strategies to restore blood circulation.

Veno-venous segment captured a significant share in 2021 and is expected to grow at a lucrative growth rate during the forecast period. The primary function of the venovenous ECMO (VV ECMO) circuit is to ease the process of exchange of oxygen andcarbon dioxide. Thus, it’s a major application in cases where lung support is needed. The key drivers of the ECMO machine market are the increasing incidence of chronic obstructive pulmonary disease. According to the WHO, there were 251 million cases of COPD globally in 2016 and this number is expected to grow further in the forecast period.

Application Insight

The respiratory segment accounted for the largest market share of 44.0% in 2021. The key market drivers include the increasing prevalence of respiratory disorders and rising awareness of ECMO procedures. According to statistics published by the ELSO, over 2,600 patients suffering from respiratory illnesses in the U.S. underwent ECMO therapy in 2015.

The cardiac surgery segment also accounted for a considerable market share in 2021 owing to the increasing incidence of cardiac surgery and rising awareness about ECMO machines in cardiac surgery. According to American Heart Association, approximately 1 of every 3 deaths in the U.S. was caused by cardiovascular disease in 2016. Moreover, the increasing cost of ECMO procedures, especially in cardiac surgery is expected to drive the market. According to a study, the total direct medical costs of cardiovascular diseases are expected to reach USD 749 million by 2035.

Patient Type Insight

The adult patient segment accounted for the largest market revenue share of 59.0% in 2021 and is also expected to grow at the fastest rate during the forecast period. Consumption of alcohol,tobacco, and smoking coupled with a sedentary lifestyle are increasing the global burden of cardiac and respiratory diseases in adults. According to the report published by the Extracorporeal Life Support Organization, in January 2016, there were around 7,850 adults suffering from cardiac illnesses that required ECMO.

The pediatric segment also accounted for a considerable market share and is expected to grow at a robust pace during the forecast period. The key drivers of the segment are the increasing number of children with various pulmonary heart diseases. According to the Extracorporeal Life Support Organization, in January 2016, around 8,102 children suffered from cardiac illness and required ECMO therapy.

Regional Insight

North America dominated the market with a share of around 39.7% in 2021 owing to the presence of major players and product launches. The growth of this market in the region can be attributed to the government support for quality healthcare, high purchasing power parity, and the increasing prevalence of diseases such as chronic obstructive pulmonary disease in the U.S. and Canada. The presence of sophisticated healthcare facilities and favorable reimbursement policies has led to an increased hospital admission rate which in turn is expected to boost the usage rates in this region.

The Asia-Pacific extracorporeal membrane oxygenation market is expected to witness the fastest growth during the forecast period. Key factors driving the growth of this region are the increase in healthcare expenditure by the government and private agencies in order to improve healthcare facilities. Economic development in countries such as Japan, India, and China coupled with rising government initiatives related to the development of healthcare infrastructure and reimbursement policies are further expected to augment the market growth.

Key Companies & Market Share Insights

Major players are focused on technological collaboration and product launches. For instance, in February 2016, Terumo Cardiovascular Systems Corporation launched CAPIOX FX advance oxygenator. This device comprises advanced features, such as increased blood flow rate with a 3,000 ml reservoir and enhanced flow dynamics. Thus, such launches deliver better performance and support market growth.Some of the prominent players in the extracorporeal membrane oxygenation machine market include:

• Medtronic plc

• Sorin Group

• Terumo Cardiovascular Systems Corporation

• MAQUET Holding B.V. & Co. KG

• Medos Medizintechnik AG

• Nipro Medical Corporation

• Microport Scientific Corporation

Extracorporeal Membrane Oxygenation Machine Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 294.2 million
Revenue forecast in 2030	USD 445.7 million
Growth rate	CAGR of 5.3% from 2022 to 2030
Base year for estimation	2021
Actual estimates/Historical data	2018 - 2020
Forecast period	2022 - 2030
Market representation	Revenue in USD million and CAGR from 2022 to 2030
Regional scope	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope	U.S.; Canada; U.K.; Germany; France; Italy; Spain; Czech Republic; Russia; Poland; Turkey; Switzerland; China; Japan; India; Australia; South Korea; Vietnam; Philippines; Malaysia; Indonesia; Thailand; Mexico; Brazil; Colombia; Argentina; Chile; South Africa; Saudi Arabia; Oman; Kuwait; UAE
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Customization scope	Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, & country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global extracorporeal membrane oxygenation machine market report based on component, modality, patient type, application, and region:

• Component Outlook (Revenue, USD Million, 2018 - 2030)

  • Pumps

  • Oxygenator

  • Controllers

  • Cannula

  • Accessories

• Modality Outlook (Revenue, USD Million, 2018 - 2030)

  • Veno-Arterial

  • Veno-Venous

  • Arterio-Venous

• Patient Type Outlook (Revenue, USD Million, 2018 - 2030)

  • 新生儿

  • Pediatric

  • Adult

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Respiratory

    • 新生儿

    • Pediatric

    • Adult

  • Cardiac

    • 新生儿

    • Pediatric

    • Adult

  • ECPR

    • 新生儿

    • Pediatric

    • Adult

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K

    • Germany

    • France

    • Italy

    • Spain

    • Czech Republic

    • Russia

    • Poland

    • Turkey

    • Switzerland

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Vietnam

    • Philippines

    • Malaysia

    • Indonesia

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

    • Chile

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Oman

    • Kuwait